{
  "FULL_TEXT": "0000200406\n2023\nFY\nfalse\nJohnson & Johnson\nhttp://fasb.org/us-gaap/2023#AccountsPayableCurrent\nhttp://fasb.org/us-gaap/2023#AccountsPayableCurrent\nhttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrent\nhttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrent\nhttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent\nhttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent\nhttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent\nhttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent\nhttp://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense\nhttp://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense\n33\n0000200406\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CommonStockMember\n2023-01-02\n2023-12-31\n0000200406\njnj:A0.650NotesDue2024Member\n2023-01-02\n2023-12-31\n0000200406\njnj:A5.50NotesDue2024Member\n2023-01-02\n2023-12-31\n0000200406\njnj:A1.150NotesDue2028Member\n2023-01-02\n2023-12-31\n0000200406\njnj:A1.650NotesDue2035Member\n2023-01-02\n2023-12-31\n0000200406\n2023-07-02\niso4217:USD\n0000200406\n2024-02-09\nxbrli:shares\n0000200406\n2023-12-31\n0000200406\n2023-01-01\niso4217:USD\nxbrli:shares\n0000200406\n2022-01-03\n2023-01-01\n0000200406\n2021-01-04\n2022-01-02\n0000200406\n2021-01-03\n0000200406\nus-gaap:RetainedEarningsMember\n2021-01-03\n0000200406\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n2021-01-03\n0000200406\nus-gaap:CommonStockMember\n2021-01-03\n0000200406\nus-gaap:TreasuryStockCommonMember\n2021-01-03\n0000200406\nus-gaap:RetainedEarningsMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:TreasuryStockCommonMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n2021-01-04\n2022-01-02\n0000200406\n2022-01-02\n0000200406\nus-gaap:RetainedEarningsMember\n2022-01-02\n0000200406\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n2022-01-02\n0000200406\nus-gaap:CommonStockMember\n2022-01-02\n0000200406\nus-gaap:TreasuryStockCommonMember\n2022-01-02\n0000200406\nus-gaap:RetainedEarningsMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:TreasuryStockCommonMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:RetainedEarningsMember\n2023-01-01\n0000200406\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n2023-01-01\n0000200406\nus-gaap:CommonStockMember\n2023-01-01\n0000200406\nus-gaap:TreasuryStockCommonMember\n2023-01-01\n0000200406\nus-gaap:RetainedEarningsMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:TreasuryStockCommonMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:RetainedEarningsMember\n2023-12-31\n0000200406\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n2023-12-31\n0000200406\nus-gaap:CommonStockMember\n2023-12-31\n0000200406\nus-gaap:TreasuryStockCommonMember\n2023-12-31\njnj:Employee\n0000200406\nus-gaap:IPOMember\njnj:KenvueIncMember\n2023-05-08\n2023-05-08\n0000200406\njnj:KenvueIncMember\n2023-05-08\n0000200406\n2023-05-08\n2023-05-08\n0000200406\njnj:KenvueIncMember\njnj:JohnsonJohnsonMember\n2023-05-08\n2023-05-08\nxbrli:pure\n0000200406\njnj:KenvueIncMember\njnj:JohnsonJohnsonMember\n2023-07-02\n0000200406\njnj:KenvueIncMember\n2023-08-23\n2023-08-23\n0000200406\njnj:KenvueIncMember\njnj:JohnsonJohnsonMember\n2023-08-23\n2023-08-23\njnj:Segment\n0000200406\nsrt:MaximumMember\nus-gaap:BuildingAndBuildingImprovementsMember\n2023-12-31\n0000200406\njnj:LandAndLeaseholdImprovementsMember\nsrt:MinimumMember\n2023-12-31\n0000200406\njnj:LandAndLeaseholdImprovementsMember\nsrt:MaximumMember\n2023-12-31\n0000200406\nus-gaap:MachineryAndEquipmentMember\nsrt:MinimumMember\n2023-12-31\n0000200406\nsrt:MaximumMember\nus-gaap:MachineryAndEquipmentMember\n2023-12-31\n0000200406\nus-gaap:SoftwareDevelopmentMember\nsrt:MinimumMember\n2023-12-31\n0000200406\nsrt:MaximumMember\nus-gaap:SoftwareDevelopmentMember\n2023-12-31\n0000200406\njnj:PharmaceuticalMember\n2023-12-31\n0000200406\njnj:PharmaceuticalMember\n2023-01-01\n0000200406\nus-gaap:ShippingAndHandlingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:ShippingAndHandlingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:ShippingAndHandlingMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:ProductConcentrationRiskMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:ProductConcentrationRiskMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:ProductConcentrationRiskMember\n2022-01-03\n2023-01-01\n0000200406\n2018-01-01\n2018-12-30\n0000200406\n2018-12-31\n2019-12-29\n0000200406\nus-gaap:CashMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:SovereignDebtSecuritiesMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:RepurchaseAgreementsMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:HeldtomaturitySecuritiesMember\nus-gaap:CorporateDebtSecuritiesMember\n2023-12-31\n0000200406\nus-gaap:MoneyMarketFundsMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:BankTimeDepositsMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:HeldtomaturitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:USTreasuryAndGovernmentMember\nus-gaap:AvailableforsaleSecuritiesMember\n2023-12-31\n0000200406\nus-gaap:USGovernmentAgenciesDebtSecuritiesMember\nus-gaap:AvailableforsaleSecuritiesMember\n2023-12-31\n0000200406\njnj:OtherSovereignSecuritiesMember\nus-gaap:AvailableforsaleSecuritiesMember\n2023-12-31\n0000200406\nus-gaap:AvailableforsaleSecuritiesMember\nus-gaap:CorporateDebtSecuritiesMember\n2023-12-31\n0000200406\nus-gaap:AvailableforsaleSecuritiesMember\n2023-12-31\n0000200406\nus-gaap:CashMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:RepurchaseAgreementsMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:HeldtomaturitySecuritiesMember\nus-gaap:CorporateDebtSecuritiesMember\n2023-01-01\n0000200406\nus-gaap:MoneyMarketFundsMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:BankTimeDepositsMember\nus-gaap:HeldtomaturitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:HeldtomaturitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:USTreasuryAndGovernmentMember\nus-gaap:AvailableforsaleSecuritiesMember\n2023-01-01\n0000200406\nus-gaap:USGovernmentAgenciesDebtSecuritiesMember\nus-gaap:AvailableforsaleSecuritiesMember\n2023-01-01\n0000200406\nus-gaap:AvailableforsaleSecuritiesMember\nus-gaap:CorporateDebtSecuritiesMember\n2023-01-01\n0000200406\nus-gaap:AvailableforsaleSecuritiesMember\n2023-01-01\n0000200406\njnj:LandAndLeaseholdImprovementsMember\n2023-12-31\n0000200406\njnj:LandAndLeaseholdImprovementsMember\n2023-01-01\n0000200406\nus-gaap:BuildingAndBuildingImprovementsMember\n2023-12-31\n0000200406\nus-gaap:BuildingAndBuildingImprovementsMember\n2023-01-01\n0000200406\nus-gaap:MachineryAndEquipmentMember\n2023-12-31\n0000200406\nus-gaap:MachineryAndEquipmentMember\n2023-01-01\n0000200406\nus-gaap:ConstructionInProgressMember\n2023-12-31\n0000200406\nus-gaap:ConstructionInProgressMember\n2023-01-01\n0000200406\njnj:PatentsAndTrademarksMember\n2023-12-31\n0000200406\njnj:PatentsAndTrademarksMember\n2023-01-01\n0000200406\nus-gaap:OtherIntangibleAssetsMember\n2023-12-31\n0000200406\nus-gaap:OtherIntangibleAssetsMember\n2023-01-01\n0000200406\nus-gaap:TrademarksMember\n2023-12-31\n0000200406\nus-gaap:TrademarksMember\n2023-01-01\n0000200406\njnj:PurchasedInProcessResearchAndDevelopmentMember\n2023-12-31\n0000200406\njnj:PurchasedInProcessResearchAndDevelopmentMember\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\n2022-01-02\n0000200406\njnj:MedTechMember\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\n2023-01-01\n0000200406\njnj:MedTechMember\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\n2023-12-31\n0000200406\njnj:MedTechMember\n2023-12-31\n0000200406\nus-gaap:ForeignExchangeContractMember\n2023-12-31\n0000200406\nus-gaap:ForeignExchangeContractMember\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\n2023-12-31\n0000200406\nus-gaap:InterestRateSwapMember\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\n2023-01-01\n0000200406\nus-gaap:InterestRateSwapMember\n2023-01-01\n0000200406\nus-gaap:SalesMember\nus-gaap:InterestRateSwapMember\nus-gaap:FairValueHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:InterestRateSwapMember\nus-gaap:FairValueHedgingMember\nus-gaap:CostOfSalesMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:InterestRateSwapMember\nus-gaap:FairValueHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:InterestRateSwapMember\njnj:InterestIncomeExpenseNetMember\nus-gaap:FairValueHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:InterestRateSwapMember\njnj:OtherIncomeExpenseNetMember\nus-gaap:FairValueHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:SalesMember\nus-gaap:InterestRateSwapMember\nus-gaap:FairValueHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:InterestRateSwapMember\nus-gaap:FairValueHedgingMember\nus-gaap:CostOfSalesMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:InterestRateSwapMember\nus-gaap:FairValueHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:InterestRateSwapMember\njnj:InterestIncomeExpenseNetMember\nus-gaap:FairValueHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:InterestRateSwapMember\njnj:OtherIncomeExpenseNetMember\nus-gaap:FairValueHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:SalesMember\nus-gaap:FairValueHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:FairValueHedgingMember\nus-gaap:CostOfSalesMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:FairValueHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\njnj:InterestIncomeExpenseNetMember\nus-gaap:FairValueHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\njnj:OtherIncomeExpenseNetMember\nus-gaap:FairValueHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:SalesMember\nus-gaap:FairValueHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:FairValueHedgingMember\nus-gaap:CostOfSalesMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:FairValueHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\njnj:InterestIncomeExpenseNetMember\nus-gaap:FairValueHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\njnj:OtherIncomeExpenseNetMember\nus-gaap:FairValueHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:SalesMember\nus-gaap:CashFlowHedgingMember\nus-gaap:ForeignExchangeContractMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CashFlowHedgingMember\nus-gaap:ForeignExchangeContractMember\nus-gaap:CostOfSalesMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:CashFlowHedgingMember\nus-gaap:ForeignExchangeContractMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CashFlowHedgingMember\njnj:InterestIncomeExpenseNetMember\nus-gaap:ForeignExchangeContractMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OtherIncomeExpenseNetMember\nus-gaap:CashFlowHedgingMember\nus-gaap:ForeignExchangeContractMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:SalesMember\nus-gaap:CashFlowHedgingMember\nus-gaap:ForeignExchangeContractMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CashFlowHedgingMember\nus-gaap:ForeignExchangeContractMember\nus-gaap:CostOfSalesMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:CashFlowHedgingMember\nus-gaap:ForeignExchangeContractMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CashFlowHedgingMember\njnj:InterestIncomeExpenseNetMember\nus-gaap:ForeignExchangeContractMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OtherIncomeExpenseNetMember\nus-gaap:CashFlowHedgingMember\nus-gaap:ForeignExchangeContractMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:SalesMember\nus-gaap:CashFlowHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:CashFlowHedgingMember\nus-gaap:CostOfSalesMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:CashFlowHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:CashFlowHedgingMember\njnj:InterestIncomeExpenseNetMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\njnj:OtherIncomeExpenseNetMember\nus-gaap:CashFlowHedgingMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:SalesMember\nus-gaap:CashFlowHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:CashFlowHedgingMember\nus-gaap:CostOfSalesMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:ResearchAndDevelopmentExpenseMember\nus-gaap:CashFlowHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\nus-gaap:CashFlowHedgingMember\njnj:InterestIncomeExpenseNetMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\njnj:OtherIncomeExpenseNetMember\nus-gaap:CashFlowHedgingMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:LongTermDebtMember\nus-gaap:DesignatedAsHedgingInstrumentMember\n2023-12-31\n0000200406\nus-gaap:LongTermDebtMember\nus-gaap:DesignatedAsHedgingInstrumentMember\n2023-01-01\n0000200406\nus-gaap:NondesignatedMember\nus-gaap:ForeignExchangeContractMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NondesignatedMember\nus-gaap:ForeignExchangeContractMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OtherIncomeExpenseNetMember\n2023-10-02\n2023-12-31\n0000200406\njnj:OtherIncomeExpenseNetMember\n2022-10-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\njnj:OtherIncomeExpenseNetMember\n2023-10-02\n2023-12-31\n0000200406\nus-gaap:CrossCurrencyInterestRateContractMember\njnj:OtherIncomeExpenseNetMember\n2022-10-03\n2023-01-01\n0000200406\nus-gaap:EquitySecuritiesMember\njnj:EquityInvestmentswithReadilyDeterminableValueMember\n2023-01-01\n0000200406\nus-gaap:EquitySecuritiesMember\njnj:EquityInvestmentswithReadilyDeterminableValueMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:EquitySecuritiesMember\njnj:EquityInvestmentswithReadilyDeterminableValueMember\n2023-12-31\n0000200406\njnj:EquityInvestmentswithoutReadilyDeterminableValueMember\nus-gaap:EquitySecuritiesMember\n2023-01-01\n0000200406\njnj:EquityInvestmentswithoutReadilyDeterminableValueMember\nus-gaap:EquitySecuritiesMember\n2023-01-02\n2023-12-31\n0000200406\njnj:EquityInvestmentswithoutReadilyDeterminableValueMember\nus-gaap:EquitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:EquitySecuritiesMember\njnj:EquityInvestmentswithReadilyDeterminableValueMember\n2022-01-02\n0000200406\nus-gaap:EquitySecuritiesMember\njnj:EquityInvestmentswithReadilyDeterminableValueMember\n2022-01-03\n2023-01-01\n0000200406\njnj:EquityInvestmentswithoutReadilyDeterminableValueMember\nus-gaap:EquitySecuritiesMember\n2022-01-02\n0000200406\njnj:EquityInvestmentswithoutReadilyDeterminableValueMember\nus-gaap:EquitySecuritiesMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:ForeignExchangeContractMember\nus-gaap:FairValueInputsLevel1Member\n2023-12-31\n0000200406\nus-gaap:ForeignExchangeContractMember\nus-gaap:FairValueInputsLevel2Member\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:ForeignExchangeContractMember\n2023-12-31\n0000200406\nus-gaap:ForeignExchangeContractMember\nus-gaap:FairValueInputsLevel2Member\n2023-01-01\n0000200406\nus-gaap:InterestRateContractMember\nus-gaap:FairValueInputsLevel1Member\n2023-12-31\n0000200406\nus-gaap:InterestRateContractMember\nus-gaap:FairValueInputsLevel2Member\n2023-12-31\n0000200406\nus-gaap:InterestRateContractMember\nus-gaap:FairValueInputsLevel3Member\n2023-12-31\n0000200406\nus-gaap:InterestRateContractMember\n2023-12-31\n0000200406\nus-gaap:InterestRateContractMember\nus-gaap:FairValueInputsLevel2Member\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel1Member\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel2Member\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel3Member\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel2Member\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel1Member\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel3Member\n2023-01-01\n0000200406\nus-gaap:OtherNoncurrentLiabilitiesMember\n2023-12-31\n0000200406\nus-gaap:OtherNoncurrentLiabilitiesMember\n2023-01-01\n0000200406\nus-gaap:OtherNoncurrentLiabilitiesMember\n2022-01-02\n0000200406\nus-gaap:OtherCurrentLiabilitiesMember\n2023-01-01\n0000200406\nus-gaap:OtherCurrentLiabilitiesMember\n2022-01-02\n0000200406\njnj:AbiomedMember\n2023-12-31\n0000200406\njnj:A6.73Debenturesdue2023Member\n2023-12-31\n0000200406\njnj:A6.73Debenturesdue2023Member\n2023-01-01\n0000200406\njnj:A3.375Notesdue2023Member\n2023-12-31\n0000200406\njnj:A3.375Notesdue2023Member\n2023-01-01\n0000200406\njnj:A2.05Notesdue2023Member\n2023-12-31\n0000200406\njnj:A2.05Notesdue2023Member\n2023-01-01\n0000200406\njnj:A0.650NotesDue2024Member\n2023-12-31\niso4217:EUR\n0000200406\njnj:A0.650NotesDue2024Member\n2023-01-01\n0000200406\njnj:A5.50NotesDue2024Member\n2023-12-31\niso4217:GBP\n0000200406\njnj:A5.50NotesDue2024Member\n2023-01-01\n0000200406\njnj:A2.625Notesdue2025Member\n2023-12-31\n0000200406\njnj:A2.625Notesdue2025Member\n2023-01-01\n0000200406\njnj:A055NotesDue2025Member\n2023-12-31\n0000200406\njnj:A055NotesDue2025Member\n2023-01-01\n0000200406\njnj:A2.45Notesdue2026Member\n2023-12-31\n0000200406\njnj:A2.45Notesdue2026Member\n2023-01-01\n0000200406\njnj:A2.95Notesdue2027Member\n2023-12-31\n0000200406\njnj:A2.95Notesdue2027Member\n2023-01-01\n0000200406\njnj:A095NotesDue2027Member\n2023-12-31\n0000200406\njnj:A095NotesDue2027Member\n2023-01-01\n0000200406\njnj:A1.150NotesDue2028Member\n2023-12-31\n0000200406\njnj:A1.150NotesDue2028Member\n2023-01-01\n0000200406\njnj:A2.900Notesdue2028Member\n2023-12-31\n0000200406\njnj:A2.900Notesdue2028Member\n2023-01-01\n0000200406\njnj:A6.95Notesdue2029Member\n2023-12-31\n0000200406\njnj:A6.95Notesdue2029Member\n2023-01-01\n0000200406\njnj:A130NotesDue2030Member\n2023-12-31\n0000200406\njnj:A130NotesDue2030Member\n2023-01-01\n0000200406\njnj:A4.95Debenturesdue2033Member\n2023-12-31\n0000200406\njnj:A4.95Debenturesdue2033Member\n2023-01-01\n0000200406\njnj:A4.375Notesdue2033Member\n2023-12-31\n0000200406\njnj:A4.375Notesdue2033Member\n2023-01-01\n0000200406\njnj:A1.650NotesDue2035Member\n2023-12-31\n0000200406\njnj:A1.650NotesDue2035Member\n2023-01-01\n0000200406\njnj:A3.55Notesdue2036Member\n2023-12-31\n0000200406\njnj:A3.55Notesdue2036Member\n2023-01-01\n0000200406\njnj:A5.95Notesdue2037Member\n2023-12-31\n0000200406\njnj:A5.95Notesdue2037Member\n2023-01-01\n0000200406\njnj:A3.625Notesdue2037Member\n2023-12-31\n0000200406\njnj:A3.625Notesdue2037Member\n2023-01-01\n0000200406\njnj:A5.85Debenturesdue2038Member\n2023-12-31\n0000200406\njnj:A5.85Debenturesdue2038Member\n2023-01-01\n0000200406\njnj:A3.400Notesdue2038Member\n2023-12-31\n0000200406\njnj:A3.400Notesdue2038Member\n2023-01-01\n0000200406\njnj:A4.50Debenturesdue2040Member\n2023-12-31\n0000200406\njnj:A4.50Debenturesdue2040Member\n2023-01-01\n0000200406\njnj:A210NotesDue2040Member\n2023-12-31\n0000200406\njnj:A210NotesDue2040Member\n2023-01-01\n0000200406\njnj:A4.85Notesdue2041Member\n2023-12-31\n0000200406\njnj:A4.85Notesdue2041Member\n2023-01-01\n0000200406\njnj:A4.50Notesdue2043Member\n2023-12-31\n0000200406\njnj:A4.50Notesdue2043Member\n2023-01-01\n0000200406\njnj:A3.70Notesdue2046Member\n2023-12-31\n0000200406\njnj:A3.70Notesdue2046Member\n2023-01-01\n0000200406\njnj:A3.75Notesdue2047Member\n2023-12-31\n0000200406\njnj:A3.75Notesdue2047Member\n2023-01-01\n0000200406\njnj:A3.500Notesdue2048Member\n2023-12-31\n0000200406\njnj:A3.500Notesdue2048Member\n2023-01-01\n0000200406\njnj:A2250NotesDue2050Member\n2023-12-31\n0000200406\njnj:A2250NotesDue2050Member\n2023-01-01\n0000200406\njnj:A2450NotesDue2060Member\n2023-12-31\n0000200406\njnj:A2450NotesDue2060Member\n2023-01-01\n0000200406\nus-gaap:OtherDebtSecuritiesMember\n2023-12-31\n0000200406\nus-gaap:OtherDebtSecuritiesMember\n2023-01-01\n0000200406\n2023-09-30\n0000200406\n2022-11-30\n0000200406\nus-gaap:CommercialPaperMember\n2023-12-31\n0000200406\nus-gaap:CommercialPaperMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:CommercialPaperMember\n2023-01-01\n0000200406\nus-gaap:CommercialPaperMember\n2022-01-03\n2023-01-01\n0000200406\n2023-10-02\n2023-12-31\n0000200406\nus-gaap:StateAndLocalJurisdictionMember\n2023-01-02\n2023-12-31\n0000200406\njnj:TalcMember\njnj:ConsumerMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:StateAndLocalJurisdictionMember\n2022-01-02\n0000200406\nus-gaap:StateAndLocalJurisdictionMember\n2021-01-04\n2022-01-02\n0000200406\n2022-10-03\n2023-01-01\n0000200406\njnj:TalcMember\njnj:ConsumerMember\n2022-01-03\n2023-01-01\n0000200406\njnj:ConsumerMember\njnj:RisperdalMember\n2022-01-03\n2023-01-01\n0000200406\njnj:AurisHealthMember\njnj:PurchasedInProcessResearchAndDevelopmentMember\n2022-10-03\n2023-01-01\n0000200406\nsrt:MaximumMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:PensionPlansDefinedBenefitMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:PensionPlansDefinedBenefitMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:PensionPlansDefinedBenefitMember\n2022-01-02\n0000200406\nus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember\n2022-01-02\n0000200406\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:ForeignPlanMember\n2023-01-02\n2023-12-31\n0000200406\ncountry:US\njnj:QualifiedPlansMember\n2023-12-31\n0000200406\ncountry:US\njnj:QualifiedPlansMember\n2023-01-01\n0000200406\ncountry:US\njnj:NonQualifiedPlansMember\n2023-12-31\n0000200406\ncountry:US\njnj:NonQualifiedPlansMember\n2023-01-01\n0000200406\njnj:FundedPlansMember\nus-gaap:ForeignPlanMember\n2023-12-31\n0000200406\njnj:FundedPlansMember\nus-gaap:ForeignPlanMember\n2023-01-01\n0000200406\njnj:UnfundedPlansMember\nus-gaap:ForeignPlanMember\n2023-12-31\n0000200406\njnj:UnfundedPlansMember\nus-gaap:ForeignPlanMember\n2023-01-01\n0000200406\nus-gaap:EquitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:EquitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:DebtSecuritiesMember\n2023-12-31\n0000200406\nus-gaap:DebtSecuritiesMember\n2023-01-01\n0000200406\njnj:ShortTermInvestmentFundsMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\njnj:ShortTermInvestmentFundsMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\njnj:ShortTermInvestmentFundsMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\njnj:ShortTermInvestmentFundsMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel3Member\njnj:ShortTermInvestmentFundsMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel3Member\njnj:ShortTermInvestmentFundsMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\njnj:ShortTermInvestmentFundsMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\njnj:ShortTermInvestmentFundsMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:DebtSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:DebtSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:DebtSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:DebtSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:DebtSecuritiesMember\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:DebtSecuritiesMember\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:DebtSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:DebtSecuritiesMember\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:EquitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:EquitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:EquitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:EquitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:EquitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:EquitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:EquitySecuritiesMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:EquitySecuritiesMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\njnj:CommingledFundsMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\njnj:CommingledFundsMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\njnj:CommingledFundsMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\njnj:CommingledFundsMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\njnj:CommingledFundsMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\njnj:CommingledFundsMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\njnj:CommingledFundsMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\njnj:CommingledFundsMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:OtherAssetsMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:OtherAssetsMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:OtherAssetsMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:OtherAssetsMember\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:OtherAssetsMember\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:OtherAssetsMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:OtherAssetsMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\nus-gaap:OtherAssetsMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueInputsLevel3Member\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-12-31\n0000200406\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:PensionPlansDefinedBenefitMember\n2023-01-01\n0000200406\nus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember\njnj:CommingledFundsMember\nus-gaap:FairValueInputsLevel2Member\n2023-12-31\n0000200406\nus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember\njnj:CommingledFundsMember\nus-gaap:FairValueInputsLevel2Member\n2023-01-01\n0000200406\nus-gaap:SubsequentEventMember\n2024-01-02\n2024-01-02\n0000200406\njnj:December172018ShareRepurchaseProgramMember\n2022-09-14\n0000200406\nus-gaap:AccumulatedTranslationAdjustmentMember\n2021-01-03\n0000200406\nus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember\n2021-01-03\n0000200406\nus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember\n2021-01-03\n0000200406\nus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember\n2021-01-03\n0000200406\nus-gaap:AccumulatedTranslationAdjustmentMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:AccumulatedTranslationAdjustmentMember\n2022-01-02\n0000200406\nus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember\n2022-01-02\n0000200406\nus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember\n2022-01-02\n0000200406\nus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember\n2022-01-02\n0000200406\nus-gaap:AccumulatedTranslationAdjustmentMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:AccumulatedTranslationAdjustmentMember\n2023-01-01\n0000200406\nus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember\n2023-01-01\n0000200406\nus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember\n2023-01-01\n0000200406\nus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember\n2023-01-01\n0000200406\nus-gaap:AccumulatedTranslationAdjustmentMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:AccumulatedTranslationAdjustmentMember\n2023-12-31\n0000200406\nus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember\n2023-12-31\n0000200406\nus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember\n2023-12-31\n0000200406\nus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember\n2023-12-31\njnj:StockBasedCompensationPlans\n0000200406\njnj:A2022LongTermIncentivePlanMember\n2023-12-31\n0000200406\nus-gaap:EmployeeStockOptionMember\n2023-01-02\n2023-12-31\n0000200406\nsrt:MinimumMember\nus-gaap:EmployeeStockOptionMember\n2023-01-02\n2023-12-31\n0000200406\nsrt:MaximumMember\nus-gaap:EmployeeStockOptionMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ExercisePriceRangeOneMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ExercisePriceRangeOneMember\n2023-12-31\n0000200406\njnj:ExercisePriceRangeTwoMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ExercisePriceRangeTwoMember\n2023-12-31\n0000200406\njnj:ExercisePriceRangeThreeMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ExercisePriceRangeThreeMember\n2023-12-31\n0000200406\njnj:ExercisePriceRangeFourMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ExercisePriceRangeFourMember\n2023-12-31\n0000200406\njnj:ExercisePriceRangeFiveMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ExercisePriceRangeFiveMember\n2023-12-31\n0000200406\nus-gaap:RestrictedStockUnitsRSUMember\nsrt:MinimumMember\n2023-01-02\n2023-12-31\n0000200406\nsrt:MaximumMember\nus-gaap:RestrictedStockUnitsRSUMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:PerformanceSharesMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:PerformanceSharesMember\nsrt:MinimumMember\n2023-01-02\n2023-12-31\n0000200406\nsrt:MaximumMember\nus-gaap:PerformanceSharesMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:RestrictedStockUnitsRSUMember\n2023-01-01\n0000200406\nus-gaap:PerformanceSharesMember\n2023-01-01\n0000200406\nus-gaap:RestrictedStockUnitsRSUMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:RestrictedStockUnitsRSUMember\n2023-12-31\n0000200406\nus-gaap:PerformanceSharesMember\n2023-12-31\n0000200406\nus-gaap:RestrictedStockUnitsRSUMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:RestrictedStockUnitsRSUMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:PerformanceSharesMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:PerformanceSharesMember\n2021-01-04\n2022-01-02\njnj:segment\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\njnj:UNITEDSTATESExportsMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\njnj:UNITEDSTATESExportsMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\njnj:UNITEDSTATESExportsMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:RemicadeMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:SimponiSimponiAriaMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\njnj:StelaraMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\njnj:StelaraMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\njnj:StelaraMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:StelaraMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:StelaraMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:StelaraMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:StelaraMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:StelaraMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:StelaraMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\njnj:TremfyaMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\njnj:TremfyaMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\njnj:TremfyaMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:TremfyaMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:TremfyaMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:TremfyaMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:TremfyaMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:TremfyaMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\njnj:TremfyaMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OtherImmunologyMember\njnj:InnovativeMedicineMember\njnj:ImmunologyMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:COVID19Member\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:COVID19Member\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:COVID19Member\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:COVID19Member\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:COVID19Member\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:COVID19Member\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:COVID19Member\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:COVID19Member\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:COVID19Member\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:EDURANTrilpivirineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:EDURANTrilpivirineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:EDURANTrilpivirineMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:EDURANTrilpivirineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:EDURANTrilpivirineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:EDURANTrilpivirineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:EDURANTrilpivirineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:EDURANTrilpivirineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:EDURANTrilpivirineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:InnovativeMedicineMember\njnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InfectiousDiseasesMember\njnj:OtherInfectiousDiseasesMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:CONCERTAMethylphenidateMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:CONCERTAMethylphenidateMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:CONCERTAMethylphenidateMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:CONCERTAMethylphenidateMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:CONCERTAMethylphenidateMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:CONCERTAMethylphenidateMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:CONCERTAMethylphenidateMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:CONCERTAMethylphenidateMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:CONCERTAMethylphenidateMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:RISPERDALCONSTAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:RISPERDALCONSTAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:RISPERDALCONSTAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:RISPERDALCONSTAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:RISPERDALCONSTAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:RISPERDALCONSTAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:RISPERDALCONSTAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:RISPERDALCONSTAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:RISPERDALCONSTAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\n2021-01-04\n2022-01-02\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\n2023-01-02\n2023-12-31\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\n2022-01-03\n2023-01-01\n0000200406\njnj:NeuroscienceMember\njnj:InnovativeMedicineMember\njnj:OTHERNEUROSCIENCEMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:CARVYKTIMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:DARZALEXMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:DARZALEXMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:DARZALEXMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:DARZALEXMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:DARZALEXMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:DARZALEXMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:DARZALEXMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:DARZALEXMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:DARZALEXMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:ErleadaMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:IMBRUVICAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:IMBRUVICAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:IMBRUVICAMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:IMBRUVICAMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:IMBRUVICAMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:IMBRUVICAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:IMBRUVICAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:IMBRUVICAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:IMBRUVICAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:ZYTIGAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:ZYTIGAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\ncountry:US\njnj:ZYTIGAMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:ZYTIGAMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:ZYTIGAMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:ZYTIGAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:ZYTIGAMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:ZYTIGAMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:InnovativeMedicineMember\njnj:ZYTIGAMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OncologyMember\njnj:OtherOncologyMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OPSUMITMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2021-01-04\n2022-01-02\n0000200406\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2021-01-04\n2022-01-02\n0000200406\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2023-01-02\n2023-12-31\n0000200406\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2022-01-03\n2023-01-01\n0000200406\njnj:UPTRAVIMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:PulmonaryHypertensionMember\njnj:OtherMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:XareltoMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:XareltoMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:XareltoMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:XareltoMember\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:XareltoMember\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:XareltoMember\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:XareltoMember\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:XareltoMember\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:XareltoMember\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:OtherMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:OtherMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:OtherMember\ncountry:US\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:OtherMember\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:OtherMember\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\njnj:OtherMember\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\njnj:OtherMember\njnj:CardiovascularMetabolismOtherMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\njnj:OtherMember\njnj:CardiovascularMetabolismOtherMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\njnj:OtherMember\njnj:CardiovascularMetabolismOtherMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\njnj:InnovativeMedicineMember\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\njnj:InnovativeMedicineMember\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:ELECTROPHYSIOLOGYMember\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ELECTROPHYSIOLOGYMember\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:ELECTROPHYSIOLOGYMember\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:ELECTROPHYSIOLOGYMember\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ELECTROPHYSIOLOGYMember\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:ELECTROPHYSIOLOGYMember\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:ELECTROPHYSIOLOGYMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:ELECTROPHYSIOLOGYMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:ELECTROPHYSIOLOGYMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:AbiomedMember\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:AbiomedMember\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:AbiomedMember\njnj:InterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:AbiomedMember\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:AbiomedMember\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:AbiomedMember\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:AbiomedMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:AbiomedMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:AbiomedMember\njnj:InterventionalSolutionsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:InterventionalSolutionsMember\njnj:OtherInterventionalSolutionsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OrthopaedicsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OrthopaedicsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OrthopaedicsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:HIPSMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:HIPSMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:HIPSMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:HIPSMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:HIPSMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:HIPSMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:HIPSMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:HIPSMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:HIPSMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:KNEESMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:KNEESMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:KNEESMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:KNEESMember\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:KNEESMember\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:KNEESMember\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:KNEESMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:KNEESMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:KNEESMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:TRAUMAMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:TRAUMAMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:TRAUMAMember\njnj:OrthopaedicsMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:TRAUMAMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:TRAUMAMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:TRAUMAMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:TRAUMAMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:TRAUMAMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:TRAUMAMember\njnj:OrthopaedicsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:OrthopaedicsMember\njnj:SPINESPORTSOTHERMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:ADVANCEDMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:ADVANCEDMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:ADVANCEDMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:ADVANCEDMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:ADVANCEDMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:ADVANCEDMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\njnj:ADVANCEDMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\njnj:ADVANCEDMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\njnj:ADVANCEDMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:GENERALMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:GENERALMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\ncountry:US\njnj:GENERALMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:GENERALMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:GENERALMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\nus-gaap:NonUsMember\njnj:GENERALMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:SurgeryMember\njnj:GENERALMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:SurgeryMember\njnj:GENERALMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:SurgeryMember\njnj:GENERALMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:VisionMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:VisionMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:VisionMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:VisionMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:VisionMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:VisionMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:VisionMember\njnj:CONTACTLENSESOTHERMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:VisionMember\ncountry:US\njnj:SURGICALMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:VisionMember\ncountry:US\njnj:SURGICALMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:VisionMember\ncountry:US\njnj:SURGICALMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:SURGICALMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:SURGICALMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:VisionMember\njnj:SURGICALMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:VisionMember\njnj:SURGICALMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\njnj:VisionMember\njnj:SURGICALMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\njnj:VisionMember\njnj:SURGICALMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\ncountry:US\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\ncountry:US\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\ncountry:US\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\njnj:MedTechMember\n2021-01-04\n2022-01-02\n0000200406\ncountry:US\n2023-01-02\n2023-12-31\n0000200406\ncountry:US\n2022-01-03\n2023-01-01\n0000200406\ncountry:US\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:NonUsMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:NonUsMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:NonUsMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:OperatingSegmentsMember\njnj:InnovativeMedicineMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:OperatingSegmentsMember\njnj:InnovativeMedicineMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:OperatingSegmentsMember\njnj:InnovativeMedicineMember\n2021-01-04\n2022-01-02\n0000200406\nus-gaap:OperatingSegmentsMember\njnj:InnovativeMedicineMember\n2023-12-31\n0000200406\nus-gaap:OperatingSegmentsMember\njnj:InnovativeMedicineMember\n2023-01-01\n0000200406\nus-gaap:OperatingSegmentsMember\njnj:MedTechMember\n2023-01-02\n2023-12-31\n0000200406\nus-gaap:OperatingSegmentsMember\njnj:MedTechMember\n2022-01-03\n2023-01-01\n0000200406\nus-gaap:OperatingSegmentsMember"
}